| Injection | Peak Area |
|---|---|
| 1 | |
| 2 | |
| 3 | |
| 4 | |
| 5 | |
| 6 |
| Mean | Standard Deviation | CV% |
|---|---|---|
| Injection | Peak Area |
|---|---|
| 1 | |
| 2 | |
| 3 | |
| 4 | |
| 5 | |
| 6 |
| Mean | Standard Deviation | CV% |
|---|---|---|
| Injection | Peak Area |
|---|---|
| 1 | |
| 2 | |
| 3 | |
| 4 | |
| 5 | |
| 6 |
| Mean | Standard Deviation | CV% |
|---|---|---|
Note: The FDA requires that acceptable criteria is: within-run and between runs: less that +/- 15% CV, except +/- 20% CV at LLOQ.